CHANDIGARH, India, March 6 /PRNewswire/ -- InnoCentive today announced
that its annual conference was held at the Indian government's National
Institute for Pharmaceutical Education and Research (NIPER), in Chandigarh,
Punjab, on Saturday, March 4, 2006. This year's event theme was, "InnoCentive
Innovation Series: Value Addition to Natural Products." Five prominent
speakers from prestigious Indian universities and institutes addressed the
conference that was attended by scientists, students and research firms from
across the country.
(Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20060306/SFM094
Commenting on the successful event, Ali Hussein, InnoCentive's chief
marketing officer, vice president of global markets, said, "Having India's
prestigious National Institute for Pharmaceutical Education and Research agree
to host this year's conference was a clear statement of the importance that
the Indian pharmaceutical industry places on innovation and global
collaboration, both hallmarks of InnoCentive's business model." Hussein
added, "We were also delighted to have the strong support and active
participation by some of India's leading scholars in the pharmaceutical field,
who shared their knowledge on R&D issues affecting India's pharmaceutical
Hussein addressed the conference along with Dr. P. Ramarao, Professor,
Director, NIPER; Dr. Bijoy Kundu, deputy director, Division of Medicinal
Chemistry, Central Drug Research Institute, Lucknow; Dr. Virinder S. Parmar,
professor, Department of Chemistry, University of Delhi; Dr. G.N. Qazi,
director, Regional Research Laboratory, Jammu; Dr. Mukund K. Gurjar, deputy
director, Division of Organic Chemistry: Technology at the National Chemical
Laboratory, Pune; and Dr. K.K. Bhutani, dean, NIPER's Department of Natural
Declared an "Institute of National Importance" by the Indian government,
NIPER is located in the city of Chandigarh in India's Punjab province, and was
established as a center for advanced studies and research for the
pharmaceutical sciences. NIPER operates under the aegis of the Ministry of
Chemicals and Fertilizers. The institute provides leadership for the
pharmaceutical sciences and related areas not only within India, but also to
countries in South East Asia, South Asia and Africa.
InnoCentive offers companies an opportunity to increase their R&D
potential by posting challenges to a confidential online forum and gaining
access to leading scientific minds. InnoCentive has developed a solid global
brand with their unique virtual R&D network of over 90,000 scientists spanning
more than 175 countries that has greatly helped companies reduce the
escalating costs and shorten the time required to bring products to market.
InnoCentive's goal is to further advance scientific research and collaboration
in worldwide markets.
InnoCentive is the first online forum that allows world-class scientists
and science-based companies to collaborate in a global scientific community to
achieve innovative solutions to complex challenges. Companies including
Boeing, Eli Lilly and Company, Procter & Gamble and others, which collectively
spend billions of dollars on R&D, post scientific problems confidentially on
the InnoCentive Web site where more than 90,000 scientists and scientific
organizations in more than 175 countries can solve them. Scientists who
deliver solutions that best meet InnoCentive's challenge requirements receive
financial awards ranging up to and over $100,000. To learn more and to
register as an InnoCentive Solver, visit the InnoCentive Web site at
NOTE: InnoCentive and InnoCentive Challenge are registered trademarks of
InnoCentive, Inc. Other product or service names mentioned herein are the
trademarks of their respective owners.
Contact: Ali Hussein, Chief Marketing Officer, Vice President of Global
Markets of InnoCentive, +1-978-482-3366; or Micky Huang, +1-510-226-6780, ext.
154, or firstname.lastname@example.org, for InnoCentive.
SOURCE InnoCentive, Inc.